Mayumi Yoshimori

Tokyo Medical and Dental University — Japan

Medicine · Health Sciences

10h-index473citations28works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(21), Lymphoma Diagnosis and Treatment(16), Immune Cell Function and Interaction(10), Eosinophilic Disorders and Syndromes(6), Cytomegalovirus and herpesvirus research(4)

Publications28 total

Expression profiling of Epstein–Barr virus-derived microRNA in systemic chronic active EBV disease
International Journal of Hematology·2025· 2 cited
Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease
Scientific Reports·2025Open Access
Functional Analysis of EBV-Derived microRNAs in Systemic Chronic Active EBV Disease Using Novel Antisense Oligonucleotides
Blood·2024Open Access
The Potential of Plasma CXCL10 As a Biomarker That Reflects Pathogenesis and Prognosis in Systemic Chronic Active EBV Disease
Blood·2024
JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study
Blood Neoplasia·2024· 4 citedOpen Access
Clinical significance of anti-Epstein–Barr virus antibodies in systemic chronic active Epstein–Barr virus disease
Frontiers in Microbiology·2024· 6 citedOpen Access
Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial
Blood·2022· 2 cited
Expression Profile of EBV-Derived Micro-RNA in Systemic Chronic Active EBV Disease
Blood·2022
Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection
Frontiers in Virology·2022· 4 citedOpen Access
The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection
Frontiers in Microbiology·2022· 5 citedOpen Access
Simvastatin Induces Anti-Tumor Effects on Systemic CAEBV <i>In Vitro</i> and <i>In Vivo</i>
Journal of St Marianna University·2022Open Access
The Plasma Level of IL-1β As a Biomarker of Angiopathy in Systemic Chronic Active EBV Infection
Blood·2021
What Plasma Level of Interferon-γ Indicates in Systemic Chronic Active Epstein-Barr Virus Infection
Blood·2021
Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
Cancers·2021· 12 citedOpen Access
Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection
Blood Advances·2021· 13 citedOpen Access
Gene expression profiling of primary vitreoretinal lymphoma
Cancer Science·2020· 32 citedOpen Access
Efficient recruitment of c‐FLIP<sub>L</sub> to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma
Cancer Science·2020· 2 citedOpen Access
[Cerebrospinal fluid findings in chronic active Epstein-Barr virus infection with central nervous system involvement].
PubMed·2019· 2 cited
<i>CD79B </i>mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential
European Journal Of Haematology·2018· 76 cited
STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
Oncotarget·2018· 48 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ayako Arai(27), Ken‐Ichi Imadome(16), Ayaka Ohashi(12), Miwako Nishio(12), Osamu Miura(11), Norio Shimizu(10), Shigeyoshi Fujiwara(9), Takatoshi Koyama(8), Yu Uemura(7), Kouhei Yamamoto(6), Morito Kurata(6), Naomi Wada(5), Honami Takada(4), Haruna Shibayama(4), Ludan Wang(3), Yasunori Saitoh(3), Shoji Yamaoka(3), Norio Shimizu(3), Kotaro Yoshioka(3), Takanori Yokota(3)